Xeris Pharmaceuticals, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Other Events, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits